Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model-Reference-Cited by-同舟云学术

Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model

Published:2021-10 Issue:1 Volume:104 Page:21-29
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Hashimoto Kei,Yamada Yoshihito,Fujikawa Mika,Sekiguchi Kota,Uratsuji Hideya,Mori Sachi,Watanabe Hideki,Matsumoto Tatsumi

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference42 articles.

1. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009;Mirzoyev;J. Invest. Dermatol.,2014

2. Alopecia areata and health-related quality of life: a systematic review and meta-analysis;Rencz;Br. J. Dermatol.,2016

4. Alopecia areata. A.N. Evaluation of 736 patients;Muller;Arch. Dermatol.,1963

5. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases;Pericin;Dermatology,1998

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies;Current Protocols;2024-08

2. Advances in the Research of the Immunological Mechanisms of Alopecia Areata;Advances in Clinical Medicine;2024

3. Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing;Proceedings of the National Academy of Sciences;2023-07-10

4. Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance;International Journal of Molecular Sciences;2022-10-30

5. Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications;Frontiers in Immunology;2022-06-03